Back to Screener

Alignment Healthcare, Inc. Common Stock (ALHC)

Price$13.30
Value ScoreD
Growth ScoreA
Momentum ScoreD

Favorite Metrics

Price vs S&P 500 (26W)-20.60%
Price vs S&P 500 (4W)-29.35%
VGM Score49.20
Market Capitalization$3.17B

All Metrics

P/CF (Annual)22.63x
Book Value / Share (Quarterly)$1.00
P/TBV (Annual)22.62x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)40.16%
Cash Flow / Share (Quarterly)$1.09
Price vs S&P 500 (YTD)-33.36%
Gross Margin (TTM)12.38%
Net Profit Margin (TTM)0.47%
EPS (TTM)$0.09
10-Day Avg Trading Volume3.72M
EPS Excl Extra (TTM)$0.09
Revenue Growth (5Y)32.71%
EPS (Annual)$-0.00
ROI (Annual)-0.14%
Gross Margin (Annual)12.37%
Net Profit Margin (5Y Avg)-8.00%
Cash / Share (Quarterly)$3.51
P/E Basic Excl Extra (TTM)159.91x
Revenue Growth QoQ (YoY)33.26%
ROA (Last FY)-0.07%
Revenue Growth TTM (YoY)41.81%
EBITD / Share (TTM)$0.32
ROE (5Y Avg)-69.91%
Operating Margin (TTM)0.84%
Cash Flow / Share (Annual)$0.55
P/B Ratio15.31x
P/B Ratio (Quarterly)17.40x
Net Income / Employee (Annual)$-400
EV / Revenue (TTM)0.65x
Net Interest Coverage (TTM)0.94x
ROA (TTM)1.79%
EV / EBITDA (TTM)42.01x
EPS Incl Extra (Annual)$-0.00
Current Ratio (Annual)1.71x
Quick Ratio (Quarterly)1.39x
3-Month Avg Trading Volume3.97M
52-Week Price Return2.82%
EV / Free Cash Flow (Annual)24.62x
P/E Incl Extra (TTM)159.91x
Revenue / Employee (TTM)$2,302,300
Tangible BV / Share (Quarterly)$0.98
P/S Ratio (Annual)0.80x
Asset Turnover (Annual)3.71x
52-Week High$23.87
Operating Margin (5Y Avg)-6.98%
EPS Excl Extra (Annual)$-0.00
CapEx CAGR (5Y)11.26%
26-Week Price Return-4.67%
Quick Ratio (Annual)1.54x
13-Week Price Return-24.98%
Total Debt / Equity (Annual)1.80x
Current Ratio (Quarterly)1.58x
Enterprise Value$2.79B
Revenue / Share Growth (5Y)31.24%
Asset Turnover (TTM)3.84x
Revenue / Employee (Annual)$2,135,600
Pretax Margin (Annual)-0.02%
Cash / Share (Annual)$2.96
3-Month Return Std Dev60.38%
Gross Margin (5Y Avg)11.65%
Net Income / Employee (TTM)$10,700
EBITDA CAGR (5Y)35.35%
EBITDA Interim CAGR (5Y)-5.25%
ROE (Last FY)-0.40%
Net Interest Coverage (Annual)2.25x
EPS Basic Excl Extra (Annual)$-0.00
P/FCF (TTM)11.25x
Receivables Turnover (TTM)39.26x
EV / Free Cash Flow (TTM)12.32x
Total Debt / Equity (Quarterly)1.56x
EPS Incl Extra (TTM)$0.09
Receivables Turnover (Annual)39.26x
ROI (TTM)4.00%
P/S Ratio (TTM)0.74x
Pretax Margin (5Y Avg)-8.00%
Revenue / Share (Annual)$19.94
Tangible BV / Share (Annual)$0.86
Forward P/E53.96x
Price vs S&P 500 (52W)-25.39%
P/E Ratio (TTM)159.91x
Year-to-Date Return-22.43%
5-Day Price Return-6.30%
EPS Normalized (Annual)$-0.00
ROA (5Y Avg)-19.20%
Net Profit Margin (Annual)-0.02%
Month-to-Date Return-32.03%
Cash Flow / Share (TTM)$-0.74
EBITD / Share (Annual)$0.22
Operating Margin (Annual)0.37%
LT Debt / Equity (Annual)1.80x
P/CF (TTM)12.57x
ROI (5Y Avg)-31.42%
P/E Excl Extra (TTM)159.91x
LT Debt / Equity (Quarterly)1.56x
EPS Basic Excl Extra (TTM)$0.09
P/TBV (Quarterly)17.79x
P/B Ratio (Annual)22.04x
Pretax Margin (TTM)0.47%
Book Value / Share (Annual)$0.88
Price vs S&P 500 (13W)-34.72%
Beta1.17x
P/FCF (Annual)27.99x
Revenue / Share (TTM)$19.97
ROE (TTM)11.50%
52-Week Low$11.63
vGradeD
gGradeA
mGradeD
vgmGradeC
Show chart for

Earnings Surprise History

Q1 260.05est. 0.01

Analyst Recommendations

Feb 2026
Mar 2026
Apr 2026
May 2026
4.26
4.26
4.26
4.30

Industry Peers — Hospital & Medical Insurance(9)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
ALHCAlignment Healthcare, Inc. Common Stock
DAD$13.30
UNHUNITEDHEALTH GROUP INCORPORATED (Delaware)DDA$379.86
ELVElevance Health, Inc.DDA$402.66
CIThe Cigna GroupCCC$274.19
HUMHumana Inc.DDA$328.31
CNCCentene CorporationBBA$62.00
MOHMolina Healthcare, Inc.DDC$183.25
OSCROscar Health, Inc.BAA$22.97
CLOVClover Health Investments, CorpDAA$3.92
TRUPTrupanion, Inc.DAF$22.26

About

Alignment Healthcare Inc markets and sells Medicare Advantage plans directly to senior consumers, allowing beneficiaries to select their coverage annually. The company operates an integrated platform combining technology and clinical care management to deliver health plans and services. This direct-to-consumer model aims to improve health outcomes and operational efficiency in the Medicare market.